New study finds common virus may improve skin cancer treatment outcomes
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.Cytomegalovirus (CMV) is a common virus that, while typically asymptomatic, is carried for life by around 50–60% of UK adults. In healthy individuals, CMV is kept in a dormant state by the immune system; however, this process profoundly reshapes how the immune…